Skip to main content

Logo
  • Live News iconLive News
  • Smart Screener iconSmart Screener
  • Trade Opportunities iconTrade Opportunities
  • Alpha Watch iconAlpha Watch
  • Catalyst iconCatalyst
Skip to main content
Stock Ask Logo
Hi, Guest User

Log in or create an account to get full access

Open an Account (opens in a new window)

TOOLS

Live News
Smart Screener
Trade Opportunities
Alpha Watch
Catalyst

StockkASK powered by Indira Securities

Coral Laboratories Ltd (CORALAB) Share Price & Fundamentals

Company Overview

Founded Year

1997

Listed Year

-

Headquarter

India

MD/CEO

-

Website

https://www.corallab.com

Company Facts

What we do

Coral Laboratories Ltd manufactures pharmaceutical formulations including generic branded, nutraceuticals, OTC, and herbal medicines, operating plants in India.

Founded in

1,997

Market share

Established player in Indian pharmaceuticals with export presence, generating steady revenue growth and diversified product portfolio.

Problem solved

Provides affordable and accessible pharmaceutical and healthcare products addressing diverse medical and wellness needs.

Top clients or who we serve

Serves healthcare providers, retailers, and consumers in India and international markets including Ethiopia and others.

Key management

-

Our journey and innovations

Since 1997, expanded manufacturing to Daman and Dehradun, continuously enhancing product range and quality with a focus on generics and nutraceuticals.

Where we operate

India, Ethiopia, and other international markets (Rest of World segment).

Top products or what we offer

Pharmaceutical formulations: tablets, capsules, liquids, topical preparation; generic branded drugs, nutraceuticals, OTC and herbal medicines.

Top brands

-

Raw materials needed

Active pharmaceutical ingredients and herbal extracts sourced for formulations.

Raw materials supplier

-

Recurring vs cyclical contribution

Revenue primarily recurring from pharmaceutical product sales.

Our industry position

Mid-sized pharmaceutical manufacturer with export footprint and growing revenues in generics and healthcare segments.

Financial highlights

FY 2024-25 revenue approx. Rs. 124 crore; net profit Rs. 24 crore; consistent earnings growth year-over-year.

Geographical revenue split

24.7% from Ethiopia, 21.9% from India, and 66.6% from Rest of World markets.

Order book

-

Whats driving growth

Export expansion, diversified product portfolio, and focus on nutraceutical and herbal medicines.

Our future plans

No major expansions reported; emphasis on operational efficiency and sustained growth in core pharmaceutical segment.

Our green promise

Energy conservation initiatives and CSR focused on social welfare and environmental responsibility.

Our people and values

Around 197 employees; committed to ethical conduct, compliance, and workforce wellbeing.

Key challenges ahead

Regulatory compliance, global competition, and currency fluctuations impacting export revenues.

Interesting facts

Operates manufacturing units across India with a long-standing export presence to emerging markets.

Risks and strategy

Focus on compliance and diversification to mitigate market risks and maintain steady financial performance.

Market Footprint

Top Clients

Top Clients

Serves healthcare providers, retailers, and consumers in India and international markets including Ethiopia and others.

Top Products

Top Products

Pharmaceutical formulations: tablets, capsules, liquids, topical preparation; generic branded drugs, nutraceuticals, OTC and herbal medicines.

Price Movement & Share Holding

Today's High/Low

500521

52 Week High/Low

360679
Past Returns

1 week

-2.5%

1 month

-8.21%

3 month

-13.06%

1 year

3.23%

3 year

73.74%

5 year

37.77%

Share Holding

Promoters

71.51%

FII

0%

DII

0%

Retail

24.5%

Others

3.99%

Company Overview

Founded Year

1997

Listed Year

-

Headquarter

India

MD/CEO

-

Website

https://www.corallab.com

Price Movement & Share Holding

Today's High/Low

500521

52 Week High/Low

360679

Past Returns

1 week

-2.5%

1 month

-8.21%

3 month

-13.06%

1 year

3.23%

3 year

73.74%

5 year

37.77%

Share Holding

Promoters

71.51%

FII

0%

DII

0%

Retail

24.5%

Others

3.99%

Company Facts

What we do

Coral Laboratories Ltd manufactures pharmaceutical formulations including generic branded, nutraceuticals, OTC, and herbal medicines, operating plants in India.

Founded in

1997

Market share

Established player in Indian pharmaceuticals with export presence, generating steady revenue growth and diversified product portfolio.

Problem solved

Provides affordable and accessible pharmaceutical and healthcare products addressing diverse medical and wellness needs.

Top clients or who we serve

Serves healthcare providers, retailers, and consumers in India and international markets including Ethiopia and others.

Our journey and innovations

Since 1997, expanded manufacturing to Daman and Dehradun, continuously enhancing product range and quality with a focus on generics and nutraceuticals.

Where we operate

India, Ethiopia, and other international markets (Rest of World segment).

Top products or what we offer

Pharmaceutical formulations: tablets, capsules, liquids, topical preparation; generic branded drugs, nutraceuticals, OTC and herbal medicines.

Raw materials needed

Active pharmaceutical ingredients and herbal extracts sourced for formulations.

Recurring vs cyclical contribution

Revenue primarily recurring from pharmaceutical product sales.

Our industry position

Mid-sized pharmaceutical manufacturer with export footprint and growing revenues in generics and healthcare segments.

Financial highlights

FY 2024-25 revenue approx. Rs. 124 crore; net profit Rs. 24 crore; consistent earnings growth year-over-year.

Geographical revenue split

24.7% from Ethiopia, 21.9% from India, and 66.6% from Rest of World markets.

Whats driving growth

Export expansion, diversified product portfolio, and focus on nutraceutical and herbal medicines.

Our future plans

No major expansions reported; emphasis on operational efficiency and sustained growth in core pharmaceutical segment.

Our green promise

Energy conservation initiatives and CSR focused on social welfare and environmental responsibility.

Our people and values

Around 197 employees; committed to ethical conduct, compliance, and workforce wellbeing.

Key challenges ahead

Regulatory compliance, global competition, and currency fluctuations impacting export revenues.

Interesting facts

Operates manufacturing units across India with a long-standing export presence to emerging markets.

Risks and strategy

Focus on compliance and diversification to mitigate market risks and maintain steady financial performance.

Market Footprint

Top Clients

Top Clients

Serves healthcare providers, retailers, and consumers in India and international markets including Ethiopia and others.

Top Products

Top Products

Pharmaceutical formulations: tablets, capsules, liquids, topical preparation; generic branded drugs, nutraceuticals, OTC and herbal medicines.

StockkASK provides smart, AI-powered insights to support analysis. AI can make mistakes; verify independently before investing.Terms & Conditions